InMed Pharmaceuticals, Inc. (INM)
1.33
-0.02
(-1.48%)
USD |
NASDAQ |
Oct 02, 16:00
1.333
0.00 (0.00%)
After-Hours: 20:00
InMed Pharmaceuticals Cash from Operations (TTM) : -8.628M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.628M |
| March 31, 2026 | -8.040M |
| December 31, 2025 | -7.843M |
| September 30, 2025 | -7.940M |
| June 30, 2025 | -8.159M |
| March 31, 2025 | -6.800M |
| December 31, 2024 | -7.202M |
| September 30, 2024 | -6.571M |
| June 30, 2024 | -6.918M |
| March 31, 2024 | -6.692M |
| December 31, 2023 | -6.383M |
| September 30, 2023 | -7.183M |
| June 30, 2023 | -7.264M |
| March 31, 2023 | -10.52M |
| December 31, 2022 | -14.14M |
| September 30, 2022 | -15.05M |
| June 30, 2022 | -15.45M |
| March 31, 2022 | -13.66M |
| December 31, 2021 | -13.98M |
| September 30, 2021 | -11.51M |
| June 30, 2021 | -10.23M |
| March 31, 2021 | -9.277M |
| December 31, 2020 | -5.150M |
| September 30, 2020 | -6.153M |
| June 30, 2020 | -7.146M |
| Date | Value |
|---|---|
| March 31, 2020 | -7.671M |
| December 31, 2019 | -8.277M |
| September 30, 2019 | -7.601M |
| June 30, 2019 | -6.554M |
| March 31, 2019 | -5.791M |
| December 31, 2018 | -4.465M |
| September 30, 2018 | -3.859M |
| June 30, 2018 | -3.618M |
| March 31, 2018 | -3.348M |
| December 31, 2017 | -3.339M |
| September 30, 2017 | -3.198M |
| June 30, 2017 | -2.288M |
| March 31, 2017 | -1.665M |
| December 31, 2016 | -0.9576M |
| September 30, 2016 | -0.4231M |
| June 30, 2016 | -0.3875M |
| March 31, 2016 | -1.031M |
| December 31, 2015 | -1.669M |
| September 30, 2015 | -1.648M |
| June 30, 2015 | -1.623M |
| March 31, 2015 | -1.491M |
| December 31, 2014 | -0.8176M |
| September 30, 2014 | -0.7299M |
| June 30, 2014 | -0.6274M |
| March 31, 2014 | 0.0001M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| NervGen Pharma Corp. | -18.43M |
| Milestone Pharmaceuticals, Inc. | -60.75M |
| Clearmind Medicine, Inc. | -6.997M |
| Lexaria Bioscience Corp. | -7.426M |
| Target Group, Inc. (Canada) | -1.073M |